201 related articles for article (PubMed ID: 12889528)
1. High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers.
Kang BC; Yang CQ; Rhee JE; Suh OK; Shin WG
Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):371-7. PubMed ID: 12889528
[TBL] [Abstract][Full Text] [Related]
2. A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies.
Zhou ZL; Yang M; Yu XY; Peng HY; Shan ZX; Chen SZ; Lin QX; Liu XY; Chen TF; Zhou SF; Lin SG
Biomed Chromatogr; 2007 Oct; 21(10):1045-51. PubMed ID: 17549677
[TBL] [Abstract][Full Text] [Related]
3. Determination of a chemopreventive agent, Oltipraz, in rat plasma and urine by high-performance liquid chromatography.
Bae SK; Bu SC; Kim EJ; Kim SH; Kim SG; Lee MG
Res Commun Mol Pathol Pharmacol; 2001; 110(1-2):133-8. PubMed ID: 12090351
[TBL] [Abstract][Full Text] [Related]
4. Effect of age on the pharmacokinetics of orally and intravenously administered terazosin.
Sennello LT; Sonders RC; Glassman HN; Jordan DC; Luther RR; Tolman KG
Clin Ther; 1988; 10(5):600-7. PubMed ID: 2908805
[TBL] [Abstract][Full Text] [Related]
5. LC-MS determination and relative bioavailability of doxazosin mesylate tablets in healthy Chinese male volunteers.
Ma N; Liu W; Li H; Chen B; Zhu Y; Liu X; Wang F; Xiang D; Zhang B
J Pharm Biomed Anal; 2007 Feb; 43(3):1049-56. PubMed ID: 17055685
[TBL] [Abstract][Full Text] [Related]
6. Determination of a new antiulcer agent, YJA-20379-2, in human plasma and urine by high-performance liquid chromatography.
Yoon WH; Kim SH; Chung SY; Chang MS; Choi WS; Sohn SK; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Dec; 94(3):317-22. PubMed ID: 9029677
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic determination of lamivudine in human serum using liquid-liquid extraction; application to pharmacokinetic studies.
Bahrami G; Mirzaeei S; Kiani A; Mohammadi B
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):213-7. PubMed ID: 16046202
[TBL] [Abstract][Full Text] [Related]
8. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
9. Determination of a new carbapenem antibiotic, DA-1131, in rat plasma, urine, and bile by column-switching high-performance liquid chromatography.
Lee ED; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Nov; 94(2):171-80. PubMed ID: 8987114
[TBL] [Abstract][Full Text] [Related]
10. Determination of terazosin in human plasma, using high-performance liquid chromatography with fluorescence detection.
Sekhar EC; Rao TR; Sekhar KR; Naidu MU; Shobha JC; Rani PU; Kumar TV; Kumar VP
J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):137-42. PubMed ID: 9686880
[TBL] [Abstract][Full Text] [Related]
11. Determination of a new asiatic acid derivative, AS 2-006A in rat plasma and urine, and human plasma by high-performance liquid chromatography.
Kim GB; Kim YG; Jew SS; Lee MG
Res Commun Mol Pathol Pharmacol; 1999; 104(3):339-44. PubMed ID: 10741384
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans.
Yun MH; Kwon KI
J Pharm Biomed Anal; 2006 Jan; 40(1):168-72. PubMed ID: 16095861
[TBL] [Abstract][Full Text] [Related]
13. Determination of 1-(3-fluoro-4-hydroxy-5-mercaptomethyltetrahydrofuran-2-yl)-5-methyl-1H-pyrimidine-2,4-dione in rat plasma and urine by high-performance liquid chromatography.
Chung HJ; Kim YC; Koo CH; Lee MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):367-70. PubMed ID: 15063349
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic modelling of arterial haemodynamic effects of terazosin in healthy volunteers.
Campanero MA; Sádaba B; Muñoz-Juarez MJ; Quetglas EG; Azanza JR
Clin Drug Investig; 2008; 28(3):139-47. PubMed ID: 18266399
[TBL] [Abstract][Full Text] [Related]
15. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.
Taguchi K; Schäfers RF; Michel MC
Br J Clin Pharmacol; 1998 Jan; 45(1):49-55. PubMed ID: 9489594
[TBL] [Abstract][Full Text] [Related]
16. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Zou JJ; Bian XJ; Ding L; Zhu YB; Fan HW; Xiao DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):151-7. PubMed ID: 18069077
[TBL] [Abstract][Full Text] [Related]
17. HPLC determination of captopril in human plasma and its pharmacokinetic study.
Li K; Tan L; Zhou JA
Biomed Chromatogr; 1996; 10(5):237-9. PubMed ID: 8879531
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography.
Hinz B; Auge D; Rau T; Rietbrock S; Brune K; Werner U
Biomed Chromatogr; 2003 Jun; 17(4):268-75. PubMed ID: 12833392
[TBL] [Abstract][Full Text] [Related]
19. Determination of a new antiulcer agent, YJA-20379-1 in plasma, urine, blood, and tissue homogenates by high-performance liquid chromatography.
Kim SH; Choi WS; Chang MS; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):107-12. PubMed ID: 9507573
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic method for the determination of ivermectin in plasma.
Na-Bangchang K; Banmairuroi V; Choemung A
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):848-58. PubMed ID: 17333725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
